Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study.

Science
Share

First published in British Journal of Clinical Pharmacology on 2013 Dec.
Br J Clin Pharmacol. 2013 Dec;76(6):888-96. doi: 10.1111/bcp.12129.

Authors: Brossard P, Derendorf H, Xu J, Maatouk H, Halabi A, Dingemanse J

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File

 

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board

LET’S TALK SCIENCE
Martin Mulder

Senior Vice President Corporate & Business Development

LET’S TALK BUSINESS

You May Also Like

Science 16. November 2023
Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults
Science 16. November 2023
Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects
Science 25. Mai 2023
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes